Bellevue Group »

Intellia Therapeutics shares owned by Bellevue Group

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Bellevue Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $27k 3.0k 8.99
2022-09-30 $1.7M 31k 55.97
2022-06-30 $817k 16k 51.73
2022-03-31 $1.2M 16k 72.66
2021-12-31 $2.0M 17k 118.24
2021-09-30 $2.2M 17k 134.14
2018-12-31 $216k 16k 13.64
2018-09-30 $470k 16k 28.60
2018-06-30 $458k 17k 27.37